ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom +5.6% ·
netto nieuwe posities +5.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 944.24K | $65.94M | n/a | n/a |
| Q2 2026 | 173 | +5 | 278.21M | $20.02B | +9 | −5 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | n/a | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | n/a |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | n/a | n/a |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | n/a |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | n/a | 38.28M | $6.63B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 19.84M | n/a | $3.23B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 10.62M | +1.8% | $1.73B | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 6.96M | +78.5% | $1.13B | 0.2% | ▲ Add | 3 | SEC ↗ ×5 |
| 4 | Capital World Investors ✦ | 6.56M | -1.8% | $1.07B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Norges Bank ✦ (passief) | 5.06M | +1.9% | $824.32M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.84M | -55.5% | $299.20M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 1.09M | Nieuw | $177.68M | 0.2% | New | 1 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 788.43K | -3.0% | $128.46M | 0.2% | ▼ Trim | 3 | SEC ↗ ×3 |
| 9 | Millennium Management ✦ | 425.42K | +277.6% | $69.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 293.66K | +11.7% | $47.85M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 11 | D. E. Shaw & Co. ✦ | 288.69K | +324.5% | $47.04M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 267.68K | +1269.3% | $43.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 138.24K | +632.7% | $22.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 135.25K | -37.8% | $22.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 98.39K | +90.0% | $16.03M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 13.38K | -2.4% | $2.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 7.97K | +100.8% | $1.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 2.85K | +46.2% | $464,308 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 1.70K | 0.0% | $276,981 | 0.0% | Held | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Citadel Advisors | $177.68M | 0.2% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,596 houders, 404.54M aandelen, $46.32B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.